$Utime (WTO.US)$ We have high hopes for FDA approval.[Grin] ...
We have high hopes for FDA approval.![]()
As part of UTime's global vaccine market strategy, it is particularly focused on the development of the mpox (monkeypox) vaccine.
Bowen Therapeutics conducts research on the mpox virus, and UTime has stated that it has developed a promising hexavalent recombinant protein vaccine. UTime is supervising ongoing clinical trials and future vaccine development, aiming to expedite FDA approval.
Bowen Therapeutics conducts research on the mpox virus, and UTime has stated that it has developed a promising hexavalent recombinant protein vaccine. UTime is supervising ongoing clinical trials and future vaccine development, aiming to expedite FDA approval.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
